Exploring the role of extracellular matrix proteins to develop biomarkers of plaque vulnerability and outcome

Research output: Contribution to journalReview article


Cardiovascular disease (CVD) is the most common cause of death in industrialized countries. One underlying cause is atherosclerosis, which is a systemic disease characterized by plaques of retained lipids, inflammatory cells, apoptotic cells, calcium and extracellular matrix (ECM) proteins in the arterial wall. The biologic composition of an atherosclerotic plaque determines whether the plaque is more or less vulnerable, that is prone to rupture or erosion. Here, the ECM and tissue repair play an important role in plaque stability, vulnerability and progression. This review will focus on ECM remodelling in atherosclerotic plaques, with focus on how ECM biomarkers might predict plaque vulnerability and outcome.


  • S. Holm Nielsen
  • L. Jonasson
  • K. Kalogeropoulos
  • M. A. Karsdal
  • A. L. Reese-Petersen
  • U. auf dem Keller
  • F. Genovese
  • J. Nilsson
  • I. Goncalves
External organisations
  • Nordic Bioscience AS
  • Technical University of Denmark
  • Linköping University
  • Skåne University Hospital
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cell and Molecular Biology


  • atherosclerosis, biomarkers, extracellular matrix, outcome, vulnerable plaque
Original languageEnglish
Pages (from-to)493-513
Number of pages21
JournalJournal of Internal Medicine
Issue number5
Early online date2020 Feb 3
Publication statusPublished - 2020 May
Publication categoryResearch